1. Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray
   YING WU et al, 2016, Oncology Reports CrossRef
2. Altered expression of cellular proliferation, apoptosis and the cell cycle-related genes in lung cancer cells with acquired resistance to EGFR tyrosine kinase inhibitors
   Tae-Gul Lee et al, 2017, Oncology Letters CrossRef
3. Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
   Lu Huang et al, 2022, Frontiers in Pharmacology CrossRef
4. Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells
   Marzia Del Re et al, 2018, Stem Cells CrossRef
5. Monitoring EGFR-lung cancer evolution: a possible beginning of a “methylation era” in TKI resistance prediction
   Federico Pio Fabrizio et al, 2023, Frontiers in Oncology CrossRef
6. Roles of S100 family members in drug resistance in tumors: Status and prospects
   Xin Hua et al, 2020, Biomedicine & Pharmacotherapy CrossRef
7. IGFBP3 Modulates Lung Tumorigenesis and Cell Growth through IGF1 Signaling
   Yong Antican Wang et al, 2017, Molecular Cancer Research CrossRef
8. Fluid Biomarkers in HPV and Non-HPV Related Oropharyngeal Carcinomas: From Diagnosis and Monitoring to Prognostication—A Systematic Review
   Shaun C. Lee et al, 2022, International Journal of Molecular Sciences CrossRef
9. Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA
   Kiyoshi Misawa et al, 2020, Oncogene CrossRef
10. Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer
    Herbert H. Loong et al, 2018, Current Treatment Options in Oncology CrossRef